Literature DB >> 11418709

Severe adrenal suppression by steroid nasal drops.

G Gill1, A Swift, A Jones, D Strain, P Weston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11418709      PMCID： PMC1281603          DOI： 10.1177/014107680109400711

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  10 in total

1.  Doctors and drops.

Authors:  G Gallagher; I Mackay
Journal:  BMJ       Date:  1991-09-28

2.  Childhood Cushing's syndrome induced by betamethasone nose drops, and repeat prescriptions.

Authors:  C A Findlay; J F Macdonald; A M Wallace; N Geddes; M D Donaldson
Journal:  BMJ       Date:  1998-09-12

3.  Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials.

Authors:  J M Weiner; M J Abramson; R M Puy
Journal:  BMJ       Date:  1998-12-12

4.  Iatrogenic Cushing's syndrome due to nasal betamethasone: a problem not to be sniffed at!

Authors:  C M Nutting; S R Page
Journal:  Postgrad Med J       Date:  1995-04       Impact factor: 2.401

5.  Adrenal suppression and cushingoid changes secondary to dexamethasone nose drops.

Authors:  W M Heroman; D E Bybee; J Cardin; J W Bass; R E Johnsonbaugh
Journal:  J Pediatr       Date:  1980-03       Impact factor: 4.406

6.  Cushing's syndrome due to the abuse of betamethasone nasal drops.

Authors:  D J Stevens
Journal:  J Laryngol Otol       Date:  1988-03       Impact factor: 1.469

7.  Dose response with fluticasone propionate on adrenocortical activity and recovery of basal and stimulated responses after stopping treatment.

Authors:  A M Wilson; E J Sims; B J Lipworth
Journal:  Clin Endocrinol (Oxf)       Date:  1999-03       Impact factor: 3.478

8.  Iatrogenic Cushing's syndrome due to dexamethasone nasal drops.

Authors:  R Kimmerle; A R Rolla
Journal:  Am J Med       Date:  1985-10       Impact factor: 4.965

9.  Lack of hypothalamic-pituitary-adrenal axis suppression with once-daily or twice-daily beclomethasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis.

Authors:  M D Brannan; J M Herron; P Reidenberg; M B Affrime
Journal:  Clin Ther       Date:  1995 Jul-Aug       Impact factor: 3.393

10.  Temporary inhibition of growth and adrenal suppression associated with the use of steroid nose drops.

Authors:  C E Daman Willems; R Dinwiddie; D B Grant; R P Rivers; M Zahir
Journal:  Eur J Pediatr       Date:  1994-09       Impact factor: 3.183
  10 in total
  3 in total

1.  Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study.

Authors:  Karin Hedenmalm; Xavier Kurz; Daniel Morales
Journal:  Eur J Clin Pharmacol       Date:  2019-03-05       Impact factor: 2.953

2.  Iatrogenic Cushing's syndrome as a consequence of nasal use of Betamethasone spray during pregnancy.

Authors:  A Scutelnicu; A M Panaitescu; A M Ciobanu; N Gica; R Botezatu; G Peltecu; M L Gheorghiu
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

3.  Too little or too much corticosteroid? Coexisting adrenal insufficiency and Cushing's syndrome from chronic, intermittent use of intranasal betamethasone.

Authors:  Adrienne Dow; Run Yu; John Carmichael
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2013-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.